Orchid Pharma Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Orchid Pharma Limited generated cash of $1,259,920,000, which is more than the previous year. Cash used in financing activities reached the amount of $1,670,404,000 last year. Net change in cash is therefore -$189,962,000.
Cash Flow
| 2010 | -343.17M | 14.12B | -10.76B |
|---|---|---|---|
| 2011 | 3.32B | -3.67B | -777.53M |
| 2012 | 7.37B | -2.93B | -4.80B |
| 2013 | 1.12B | -6.57B | 4.42B |
| 2016 | 2.12B | -14.56M | -2.86B |
| 2018 | 91.80M | -280.56M | 333.90M |
| 2020 | 808.03M | 1.67B | -2.50B |
| 2021 | 235.86M | 672.05M | -1.64B |
| 2023 | 185.82M | -314.58M | 311.66M |
| 2024 | 1.25B | -3.12B | 1.67B |
ORCHPHARMA.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 225.97M | 43.06M | 898.91M | 923.10M | 205.98M | 3.90B | 0 | 2.13B | 3.26B | 244.88M |
Operating activities | ||||||||||
Net income | 921.66M | 463.18M | -1.16B | -1.31B | -3.98B | -2.96B | -3.72B | 974.78M | 1.71B | 4.69B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 332.37M | 547.86M | 1.08B | 1.25B | 1.33B | 1.45B | 1.67B | 1.53B | 1.33B | 1.54B |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 4.72M | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 4.72M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 196.46M | -416.53M | -820.24M | 440.11M | 451.38M | -514.25M | -1.04B | 0 | 0 | 0 |
Inventories | -354.88M | -560.81M | -334.98M | 140.62M | 175.13M | 100.78M | 1.08B | -511.00M | -1.94B | 3.45B |
Accounts payable | 548.51M | 139.14M | 179.30M | 76.91M | -824.60M | 595.34M | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 1.25B | 185.82M | 235.86M | 808.03M | 91.80M | 2.12B | 1.12B | 7.37B | 3.32B | -343.17M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -53.07M | -130.78M | 0 | -339.73M | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -648.14M | -849.13M | -6.04M | -42.42M | -62.10M | -14.66M | -7.43B | -2.94B | -3.86B | -2.24B |
Acquisitions Net | 0 | 576.1M | 2.86M | 0 | 583K | 0 | 0 | 0 | 0 | 16.37B |
Cash generated by investing activities | -3.12B | -314.58M | 672.05M | 1.67B | -280.56M | -14.56M | -6.57B | -2.93B | -3.67B | 14.12B |
Financing activities | ||||||||||
Common Stock Issued | 3.91B | 0 | 0 | 400M | 0 | 184.34M | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -249.01M | -818.00M | -82.41M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -2.08B | 633.92M | -1.25B | -2.90B | 377.10M | -398.28M | 0 | -3.00B | -3.37B | -14.13B |
Cash used in financing activities | 1.67B | 311.66M | -1.64B | -2.50B | 333.90M | -2.86B | 4.42B | -4.80B | -777.53M | -10.76B |
Net Change In Cash | -189.96M | 182.90M | -741.97M | -24.19M | 145.14M | -756.24M | -1.02B | -361.74M | -1.13B | 3.01B |
Cash at end of period | 36.00M | 225.97M | 156.93M | 898.91M | 351.13M | 3.14B | -1.02B | 1.76B | 2.13B | 3.26B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |